Two versus three doses of a meningococcal C conjugate vaccine concomitantly administered with a hexavalent DTaP-IPV-HBV/Hib vaccine in healthy infants.

[1]  F. Domínguez,et al.  An effective serogroup B meningococcal vaccine. , 2006, Vaccine.

[2]  D. Kelly,et al.  CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells. , 2006, Blood.

[3]  R. von Kries,et al.  The Use of Combination Vaccines Has Improved Timeliness of Vaccination in Children , 2006, The Pediatric infectious disease journal.

[4]  M. Kieny,et al.  A review of vaccine research and development: meningococcal disease. , 2006, Vaccine.

[5]  D. Kelly,et al.  Lack of Serum Bactericidal Activity in Preschool Children Two Years After a Single Dose of Serogroup C Meningococcal Polysaccharide-Protein Conjugate Vaccine , 2005, The Pediatric infectious disease journal.

[6]  J. García-Sicilia,et al.  Immunogenicity and Reactogenicity of a Three-Dose Primary Vaccination Course With a Combined Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Polio-Haemophilus influenzae Type b Vaccine Coadministered With a Meningococcal C Conjugate Vaccine , 2004, The Pediatric infectious disease journal.

[7]  P. De Wals,et al.  Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine. , 2004, JAMA.

[8]  Elizabeth Miller,et al.  Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction , 2004, The Lancet.

[9]  David Goldblatt,et al.  Immunogenicity of, and Immunologic Memory to, a Reduced Primary Schedule of Meningococcal C-Tetanus Toxoid Conjugate Vaccine in Infants in the United Kingdom , 2003, Infection and Immunity.

[10]  M. Steinhoff,et al.  Conjugate Hib vaccines , 2003, The Lancet.

[11]  S. Halperin,et al.  Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study. , 2002, Clinical and investigative medicine. Medecine clinique et experimentale.

[12]  L. Shaw,et al.  Safety of a new conjugate meningococcal C vaccine in infants , 2001, Archives of disease in childhood.

[13]  M. Ramsay,et al.  Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. , 2001, Vaccine.

[14]  S. Lockhart,et al.  Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of age. , 2001, Vaccine.

[15]  G. Poland.  Adolescent Hepatitis B Immunization: Making It Simpler , 2001, Pediatrics.

[16]  J. Deeks,et al.  Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial. , 2000, JAMA.

[17]  S. Choo,et al.  Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial. , 2000, Vaccine.

[18]  D. Granoff,et al.  Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine , 2000 .

[19]  N. Noah,et al.  Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993–6 , 1999, Epidemiology and Infection.

[20]  D. Granoff,et al.  Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial. , 1998, JAMA.

[21]  B. Plikaytis,et al.  A Modified Enzyme-Linked Immunosorbent Assay for Measurement of Antibody Responses to Meningococcal C Polysaccharide That Correlate with Bactericidal Responses , 1998, Clinical Diagnostic Laboratory Immunology.

[22]  G. Carlone,et al.  Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group , 1997, Clinical and diagnostic laboratory immunology.

[23]  F. Deinhardt,et al.  Immune responses to late booster doses of hepatitis B vaccine , 1985, Journal of medical virology.

[24]  I. W. Devoe.  The meningococcus and mechanisms of pathogenicity. , 1982, Microbiological reviews.

[25]  M. Artenstein,et al.  HUMAN IMMUNITY TO THE MENINGOCOCCUS , 1969, The Journal of experimental medicine.

[26]  D. Goldblatt,et al.  Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. , 2001, The Journal of infectious diseases.

[27]  G. Carlone,et al.  Standardization and a Multilaboratory Comparison ofNeisseria meningitidisSerogroup A and C Serum Bactericidal Assays , 1997 .

[28]  R. Harpaz,et al.  Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1996, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.